Biodesix, Inc. Common Stock

BDSXNASDAQUSD
15.36 USD
0.29 (1.92%)AT CLOSE (11:59 AM EDT)
15.38
0.30 (1.95%)
POST MARKET (AS OF 05:57 PM EDT)
Post Market
AS OF 05:57 PM EDT
15.38
0.30 (1.95%)
🟢Market: OPEN
Open?$15.10
High?$16.26
Low?$15.10
Prev. Close?$15.07
Volume?97.2K
Avg. Volume?126.0K
VWAP?$15.62
Rel. Volume?0.77x
Bid / Ask
Bid?$11.87 × 100
Ask?$18.59 × 100
Spread?$6.72
Midpoint?$15.23
Valuation & Ratios
Market Cap?148.6M
Shares Out?9.9M
Float?3.2M
Float %?40.6%
P/E Ratio?N/A
P/B Ratio?-60.27
EPS?-$3.58
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.86Adequate
Quick Ratio?1.86Adequate
Cash Ratio?1.09Strong
Debt/Equity?-19.25Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
-60.27CHEAP
P/S?
1.68CHEAP
P/FCF?
N/A
EV/EBITDA?
-8.0CHEAP
EV/Sales?
2.00CHEAP
Returns & Efficiency
ROE?
1,430.6%STRONG
ROA?
-40.3%WEAK
Cash Flow & Enterprise
FCF?$-23530000
Enterprise Value?$177.0M
Related Companies
Loading...
News
Profile
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Employees
334
Market Cap
148.6M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2020-10-28
Address
919 WEST DILLON ROAD
LOUISVILLE, CO 80027
Phone: 303-417-0500